Keyphrases
Poor Outcome
100%
Estrogen Receptor-positive Breast Cancer
100%
Hyperactivity
100%
ERK2
100%
Hormone Therapy Resistance
100%
MicroRNA Signature
100%
Estrogen Receptor
83%
Breast Cancer
66%
Recurrent Disease
66%
MicroRNA
50%
Multivariate Analysis
33%
Hormone Therapy
33%
Poor Clinical Outcomes
33%
Survival Signature
33%
Clinical Outcomes
33%
Disease Survival
33%
Gene Expression
16%
Regulatory Role
16%
Therapeutic Target
16%
Disease Risk
16%
Clinical Features
16%
Genetic Modification
16%
MicroRNA Expression
16%
Disease Biomarker
16%
Pathological Features
16%
Molecular Alterations
16%
Primary Breast Cancer
16%
Predictive Biomarker
16%
Prognostic Biomarker
16%
Estrogen Receptor Status
16%
Estrogen Receptor-positive
16%
Univariate Analysis
16%
Training Data
16%
Disease-specific Mortality
16%
Pathological Outcomes
16%
Poor Response
16%
Disease-specific Survival
16%
Response-outcome
16%
Outcome Association
16%
Recurrence-free
16%
Publicly Available Dataset
16%
Cancer Receptors
16%
MAPK Signaling
16%
Luminal B Subtype
16%
Gene Signature
16%
HER2 Subtype
16%
Basal Subtype
16%
Medicine and Dentistry
Therapy Resistance
100%
microRNA
100%
Hormone Therapy
100%
Estrogen Receptor Positive Breast Cancer
100%
Estrogen Receptor
100%
Mitogen-Activated Protein Kinase
100%
Recurrent Disease
85%
Mitogen Activated Protein Kinase 3
85%
Hyperactivation
85%
Breast Cancer
71%
Diseases
57%
Biological Marker
28%
Cancer
28%
Multivariate Analysis
28%
Malignant Neoplasm
14%
Clinical Feature
14%
Gene Expression
14%
Receptor Expression
14%
Univariate Analysis
14%
Gene Mutation
14%
Disease Specific Survival
14%
MAPK Signaling
14%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Estrogen Receptor
100%
Mitogen-Activated Protein Kinase
100%
Multivariate Analysis
25%
Gene Expression
12%
Gene Mutation
12%
MAPK Signaling
12%
Disease Specific Survival
12%